JOSEPHINE OWENS: Open Payments
NPI 1598337016 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,279 in 118 payments from 15 companies in 2025. Trend: 2023 $1,192 · 2024 $1,691 · 2025 $3,279
Food & beverage: $3,279
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 27 | $639 |
| Janssen Pharmaceuticals, Inc | 7 | $495 |
| Otsuka America Pharmaceutical, Inc. | 20 | $477 |
| E.R. Squibb & Sons, L.L.C. | 7 | $309 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $266 |
| Alkermes, Inc. | 20 | $229 |
| Teva Pharmaceuticals USA, Inc. | 6 | $218 |
| Axsome Therapeutics, Inc. | 8 | $192 |
| Collegium Pharmaceutical, Inc. | 4 | $157 |
| Lundbeck LLC | 6 | $96 |
Products named: REXULTI, FANAPT, COBENFY, HETLIOZ, CAPLYTA, INVEGA SUSTENNA, SPRAVATO, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
